Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 4 (1)

Sponsor

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

ipilimumab (1)

laboratory biomarker analysis (1)

nivolumab (1)

recombinant human papillomavirus nonavalent vaccine (1)

Study Documents

Intervention Type

biological (2)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

allogeneic hematopoietic stem cell transplant recipient

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

Active, not recruiting

Allogeneic Hematopoietic Stem Cell Transplant Recipient
Hematopoietic and Lymphoid Cell Neoplasm

Recombinant Human Papillomavirus Nonavalent Vaccine

Houston, Texas

M D Anderson Cancer Center

Jun 29, 2022

Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Tumor, Recurrent Acute Lymphoblastic Leukemia Trial

Completed

Allogeneic Hematopoietic Stem Cell Transplant Recipient
+10 more

Ipilimumab
+2 more

Duarte, California
+12 more

Jun 23, 2021